Search - tctmd.com

Displaying 21 - 40 of 148

Sort: Relevancy | Date

Presentation TCT 2020

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

Presenter: Malik Shehadeh

October 14, 2020

Presentation TCT 2020

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

Presenter: Beytullah Çakal

October 14, 2020

Presentation TCT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure III: The MANTA Device

Presenter: David Wood

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure II: The InSeal Device

Presenter: Ran Kornowski

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure I: The PerQseal Device

Presenter: Jeffrey Popma

September 27, 2019

Presentation TCT 2019

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Presenter: Hendrik Treede

September 27, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 15, 2019

Presentation TVT 2019

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Presenter: Mark Hensey

June 14, 2019

Presentation TVT 2019

Illustrative Cases

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

Technology Description

Presenter: Jian Ye

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Large-Hole Transfemoral Closure I: The FDA-Approved MANTA Device

Presenter: Nicolas Van Mieghem

June 13, 2019

Presentation TVT 2019

Large-Hole Transfemoral Closure III: The PerQseal Device

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

When Transfemoral Access Is Problematic — Facilitation With Intravascular Balloon Lithotripsy

Presenter: David Wood

June 13, 2019

Presentation TVT 2019

When Transfemoral Access Isn’t Available — A Systematic Approach to Alternative Access for TAVR

Presenter: Amir Kaki

June 13, 2019

Presentation TVT 2019

Transfemoral Access for TAVR Made 'Simple' — Tips and Tricks to Optimize Outcomes

Presenter: Michael Rinaldi

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

Advertisement

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Large-Hole Transfemoral Closure III: The MANTA Device

Large-Hole Transfemoral Closure II: The InSeal Device

Large-Hole Transfemoral Closure I: The PerQseal Device

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Illustrative Cases

Technology Description

2 Illustrative Cases – A Case-Based Discussion

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Large-Hole Transfemoral Closure I: The FDA-Approved MANTA Device

Large-Hole Transfemoral Closure III: The PerQseal Device

When Transfemoral Access Is Problematic — Facilitation With Intravascular Balloon Lithotripsy

When Transfemoral Access Isn’t Available — A Systematic Approach to Alternative Access for TAVR

Transfemoral Access for TAVR Made 'Simple' — Tips and Tricks to Optimize Outcomes

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content